Entries by

Reimbursement approval from U.S. Centers for Medicare & Medicaid Services (CMS)

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. Belluscura […]

Exercise of Warrants and Total Voting Rights

Belluscura PLC (“Belluscura” or “Company”) Exercise of Warrants and Total Voting Rights LONDON, U.K. AND PLANO, TX, U.S. (29 November 2021). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received notification from a warrant holder to exercise warrants over 179,537 shares in […]

Demand for X-PLO2R™ portable oxygen concentrators significantly exceeds expectations

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. Belluscura […]

The Pulse: Healthcare Innovation Breakfast

CEO to present with London Stock Exchange Head of Primary Markets at an event in Dallas, Texas   Bob Rauker to discuss accessing alternative sources of capital and his experience of listing a Company on the Alternative Investment Market (AIM)    LONDON, U.K. AND PLANO, TX, U.S. (1 November 2021). Belluscura plc (AIM: BELL), a […]

Product wins Top Award at US Trade Show

X-PLO₂R™ wins gold award at Medtrade East 2021 in Atlanta   LONDON, U.K. AND PLANO, TX, U.S. (25 October 2021). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that its X-PLO₂R™  portable oxygen concentrator won the Providers’ Choice Gold, the highest accolade to be given at […]